RANDAL J KIRK SC 13D 3-16-2015 (AMPLIPHI BIOSCIENCES CORP)

Company

Armata Pharmaceuticals, Inc.

Filed

March 20, 2015

Accession Number

0001140361-15-012832

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →